ahlam1399
03-16-2016, 11:00 PM
UPDATE 2-Amgen beats Sa**fi, Regeneron at cholesterol drug trial
March 16 (Reuters) - A federal jury upheld the validity of two Amgen Inc patents related to the company's newly-approved drug to reduce bad cholesterol, in a defeat for Sa**fi SA and Regeneron Pharmaceuticals Inc, which make a rival drug.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e4fd1b5/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=m4D3fGhxTUs:wSu6rCf_f4E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=m4D3fGhxTUs:wSu6rCf_f4E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=m4D3fGhxTUs:wSu6rCf_f4E:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=m4D3fGhxTUs:wSu6rCf_f4E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=m4D3fGhxTUs:wSu6rCf_f4E:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/m4D3fGhxTUs
March 16 (Reuters) - A federal jury upheld the validity of two Amgen Inc patents related to the company's newly-approved drug to reduce bad cholesterol, in a defeat for Sa**fi SA and Regeneron Pharmaceuticals Inc, which make a rival drug.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e4fd1b5/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=m4D3fGhxTUs:wSu6rCf_f4E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=m4D3fGhxTUs:wSu6rCf_f4E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=m4D3fGhxTUs:wSu6rCf_f4E:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=m4D3fGhxTUs:wSu6rCf_f4E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=m4D3fGhxTUs:wSu6rCf_f4E:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/m4D3fGhxTUs